EP Patent

EP0719549A1 — Soft gelatine pharmaceutical dosage form containing a translucent gel

Assigned to Kenvue Brands LLC · Expires 1996-07-03 · 30y expired

What this patent protects

The present invention relates to a substantially translucent, gel fill material for a soft gelatin capsule containing a therapeutically effective amount of a pharmaceutical dissolved or suspended in the gel. The gel is sufficiently viscous so that it cannot be expelled at room te…

USPTO Abstract

The present invention relates to a substantially translucent, gel fill material for a soft gelatin capsule containing a therapeutically effective amount of a pharmaceutical dissolved or suspended in the gel. The gel is sufficiently viscous so that it cannot be expelled at room temperature from the capsule with a syringe.

Drugs covered by this patent

Patent Metadata

Patent number
EP0719549A1
Jurisdiction
EP
Classification
Expires
1996-07-03
Drug substance claim
No
Drug product claim
No
Assignee
Kenvue Brands LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.